Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





PhIB AS-1763 in Pts w/ Prev Treat CLL/SLL or NHL

Cancer
Catherine Coombs
A Phase IB Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Lymphoid Leukemia
Non-Hodgkin's Lymphoma

Study Description

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ≥2 lines of systemic therapy.

Eligibility

if you are at least 18 years of age

You cannot participate in this study if you are a female who is pregnant or breastfeeding or planning to become pregnant

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.